Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4068 results

Sort By:

A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection

Study ID: NCT06801223
Start Date: 2025-07-30
End Date: 2028-05-20
Study Type

Interventional

Study Phase

Phase1

No. of Participants

48

Intervention / Treatment

Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours)

Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 8 hours)

Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 8 hours)

Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 12 hours)

Sponsor

Innoviva Specialty Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Testing the Combination of Targeted Radiotherapy With Anti-Cancer Drugs, Venetoclax and ASTX-727, to Improve Outcomes for Adults With Newly Diagnosed Acute Myeloid Leukemia

Study ID: NCT06802523
Start Date: 2025-07-25
End Date: 2025-09-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

48

Intervention / Treatment

Actinium and 225 Lintuzumab

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Decitabine and Cedazuridine

Venetoclax

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Microsurgical Robot-assisted Corneal Transplant

Study ID: NCT06844123
Start Date: 2025-08
End Date: 2027-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Robot-assisted keratoplasty

Sponsor

Reims of chu

Source: clinicaltrials.gov

Share:
Add to list

Implementation of a Just-In-Time Adaptive Intervention for Adolescent Anxiety

Study ID: NCT06946823
Start Date: 2025-07-01
End Date: 2027-02-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Just-In-Time Adaptive Intervention for Adolescent Anxiety

Sponsor

Trustees of Dartmouth College

Source: clinicaltrials.gov

Share:
Add to list

Scaling Out S.A.F.E. Firearm Across Two Health Systems as a Universal Suicide Prevention Strategy (SCALE ASPIRE)

Study ID: NCT07009314
Start Date: 2026-01
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

5442

Intervention / Treatment

Implementation package (training, facilitation, electronic health record nudge)

Sponsor

Northwestern University

Source: clinicaltrials.gov

Share:
Add to list

Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)

Study ID: NCT05482295
Start Date: 2025-09
End Date: 2026-05
Study Type

Interventional

Study Phase

Phase3

No. of Participants

540

Intervention / Treatment

In-House Recombinant Hepatitis B (Bio Farma) vaccine

Registered Hepatitis B vaccine recombinant (Engerix-B)

Sponsor

PT was a farm

Source: clinicaltrials.gov

Share:
Add to list

Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM

Study ID: NCT06974604
Start Date: 2025-07-31
End Date: 2029-05-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Dexamethasone oral

Sponsor

Brown University

Source: clinicaltrials.gov

Share:
Add to list

Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI)

Study ID: NCT05559801
Start Date: 2025-09
End Date: 2026-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

12

Intervention / Treatment

Bone marrow-derived mesenchymal stromal cells (MSCs)

Sponsor

Emory University

Source: clinicaltrials.gov

Share:
Add to list

Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People Living With HIV Receiving Antiretroviral Therapy

Study ID: NCT06819176
Start Date: 2025-06-26
End Date: 2029-01-24
Study Type

Interventional

Study Phase

Phase1

No. of Participants

50

Intervention / Treatment

Lenkavir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Source: clinicaltrials.gov

Share:
Add to list

Safety and Usability of the EXPLORER Exoskeleton in Adults With Neuromuscular Diseases

Study ID: NCT06894160
Start Date: 2025-07-01
End Date: 2025-08-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

7

Intervention / Treatment

Adults EXPLORER

Sponsor

MarsiBionics

Source: clinicaltrials.gov

Share:
Add to list